Description

Sita-Met 50/500mg Tablet is a fixed-dose combination medicine used in the treatment of type 2 diabetes mellitus. It brings together two complementary anti-diabetic agents, Sitagliptin and Metformin, in a single tablet, offering a dual-action approach to blood sugar control for patients who do not achieve adequate glycemic control with a single medicine alone. This combination is typically prescribed when diet, exercise, and monotherapy with either component individually have not produced the desired results. By combining a DPP-4 inhibitor with a biguanide, Sita-Met works on two different pathways of glucose regulation at once, making it a convenient option for patients who would otherwise need to take two separate tablets. Each pack contains 14 tablets, generally intended for a two-week course based on the dosing schedule set by the prescribing physician. As with any combination diabetes therapy, this medicine should be used strictly under medical supervision, with periodic monitoring of blood sugar and organ function.

Ingredients

Sita-Met 50/500mg Tablet contains two active ingredients: Sitagliptin 50mg and Metformin Hydrochloride 500mg. Sitagliptin works by enhancing the body’s incretin response, while Metformin primarily reduces glucose production in the liver and improves the body’s sensitivity to insulin in muscle tissue. Alongside these active substances, the tablet includes inactive ingredients such as povidone, microcrystalline cellulose, sodium starch glycolate, magnesium stearate, and a polymer-based film coat that gives the tablet its finished appearance and aids in controlled disintegration after ingestion.

Dosage Form

This medicine is manufactured as a film-coated, bilayer or single-layer combination oral tablet, depending on the manufacturing process, designed to release both active ingredients for oral consumption. The tablets are packaged in blister strips that protect them from moisture and light, helping to maintain their integrity until the labelled expiry date.

Uses

Sita-Met 50/500mg Tablet is used for the comprehensive management of type 2 diabetes mellitus in adults, particularly those who require the combined effect of two glucose-lowering mechanisms. The Sitagliptin component supports insulin release in response to meals and reduces excess sugar output from the liver, while the Metformin component decreases intestinal glucose absorption, lowers hepatic glucose production, and increases peripheral tissue sensitivity to insulin. Together, these actions help achieve more effective blood sugar control than either ingredient could typically provide alone. This tablet is often prescribed for patients transitioning from single-drug therapy who need better glycemic control, and consistent adherence, along with a balanced diet and regular exercise, can help minimize the long-term risks associated with poorly controlled diabetes, including damage to the eyes, kidneys, nerves, and cardiovascular system.

How to Use

Sita-Met 50/500mg Tablet should be taken exactly as prescribed by the treating doctor, and it is generally recommended to be taken with meals to reduce the likelihood of stomach-related discomfort associated with the Metformin component. The tablet should be swallowed whole with a glass of water and should not be crushed or chewed unless the doctor specifically advises otherwise. Maintaining a consistent daily schedule helps the medicine work more effectively. Patients must not stop or alter the dose without medical guidance, as sudden discontinuation may lead to a rise in blood sugar levels. If a dose is missed, it should be taken as soon as it is remembered, unless the next dose is nearly due, in which case the missed dose should be skipped rather than combined with the next one.

Side Effects

Because Sita-Met combines two active ingredients, its side-effect profile reflects both components. Commonly reported effects include nausea, diarrhea, stomach upset, loss of appetite, and a metallic taste in the mouth, which are largely linked to the Metformin component and often improve as the body adjusts. Effects associated with the Sitagliptin component may include headache, upper respiratory tract infection, and sore throat. In rare instances, more serious reactions can occur, such as lactic acidosis (a rare but severe metabolic complication linked to Metformin, presenting as unusual muscle pain, difficulty breathing, or extreme tiredness), signs of pancreatitis, or allergic reactions such as rash and swelling. Any severe, persistent, or unusual symptoms should prompt immediate discontinuation of the medicine and consultation with a healthcare provider.

Pregnancy & Breastfeeding

The use of Sita-Met 50/500mg Tablet during pregnancy is generally not recommended unless a physician determines it is clearly necessary, as blood sugar management in pregnancy often requires alternative treatment approaches. Women who are pregnant, planning pregnancy, or breastfeeding should inform their doctor before starting this medicine so that the safest possible treatment plan can be considered. Since both active ingredients may have the potential to pass into breast milk to varying degrees, breastfeeding mothers should seek personalized medical advice before use.

Storage Instructions

Sita-Met tablets should be stored in a cool, dry place away from direct sunlight and excessive heat, ideally at temperatures below 30°C. The tablets should remain in their original blister packaging until the time of use to protect them from moisture, and they must be kept out of reach and sight of children and pets. Avoid storing the medicine in humid areas such as bathrooms, and never freeze the tablets. Always check the expiry date before use, and dispose of unused or expired tablets responsibly through appropriate medicine disposal channels rather than household waste or drains.

FAQS

Q1. Why are Sitagliptin and Metformin combined in one tablet?
Combining both ingredients allows two different mechanisms of blood sugar control to work together, often improving convenience and adherence for patients needing dual therapy.

Q2. Should this tablet be taken with food?
Yes, taking it with meals is generally recommended to help reduce stomach-related side effects linked to the Metformin component.

Q3. Is this medicine suitable for patients with kidney problems?
Metformin-containing medicines require caution in patients with reduced kidney function, so a doctor will assess kidney health before and during treatment.

Q4. Can alcohol be consumed while taking Sita-Met?
Alcohol is best avoided or limited, as it may increase the risk of a rare but serious condition called lactic acidosis when combined with Metformin.

Q5. Will long-term use affect vitamin levels in the body?
Prolonged Metformin use has been associated with reduced vitamin B12 absorption in some patients, so periodic monitoring may be advised by the doctor.

Disclaimer

Always use this medicine strictly according to your doctor’s instructions and prescribed dosage.